Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Eczema
ADR ID BADD_A01408
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.04      Dermatitis and eczema
23.03.04.006      Eczema
Description A disorder characterized by skin which becomes itchy, red, inflamed, crusty, thick, scaly, and/or forms blisters. [CTCAE] A pruritic papulovesicular dermatitis occurring as a reaction to many endogenous and exogenous agents (Dorland, 27th ed). [MeSH]
MedDRA Code 10014184
MeSH ID D004485
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Dermatitis eczematoid | Eczema | Eczema (rash) in the outer ear | Eczema acute | Eczema aggravated | Eczema exacerbated | Eczema facial | Eczema NOS | Eczema of external auditory meatus | Eczema papular | Eczematous dermatitis | Eczematous nipple | Eczematous rash | Erythematosquamous dermatosis | Generalised eczematous reaction | Other erythematosquamous dermatosis | Reaction eczematous | Generalized eczematous reaction | Epiderma spongiosis | Chronic eczema | Acute spongiotic dermatitis | Subacute spongiotic dermatitis | Disseminated secondary eczema | Chronic spongiotic dermatitis | Spongiotic dermatitis | Localised eczema | Localized eczema | Eczemas | Dermatitis, Eczematous | Dermatitides, Eczematous | Eczematous Dermatitides | Eczematous Dermatitis
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02439Levodopa0.000367%
BADD_D02450Crisaborole0.015942%
BADD_D02464Fingolimod0.006293%
BADD_D02473Sodium chloride--
BADD_D02483Ribociclib0.000112%
BADD_D02490Apalutamide0.002136%
BADD_D02492Deflazacort0.000117%
BADD_D02514Etelcalcetide0.002557%
BADD_D02515Pexidartinib0.000246%
BADD_D02520Baloxavir marboxil0.000282%
BADD_D02527Abrocitinib0.000692%
BADD_D02545Dacomitinib0.000112%
BADD_D02558Gadolinium cation (3+)-
BADD_D02574Molnupiravir0.001101%
BADD_D02636Sulfisoxazole--
The 13th Page    First    Pre   13    Total 13 Pages